CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
Uridine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01805440
NCT01805440N/ACompleted
CompareCT.gov

Placebo-Controlled Study of Uridine for Adolescent Bipolar Depression: a Magnetic Resonance Spectroscopy Study

University of Utah·interventional·Posted Mar 6, 2013·Updated Mar 12, 2018

In Brief

A clinical study evaluating Uridine and Placebo for Bipolar Disorder and 2 related conditions. Completed, enrolled 62 participants across 1 site.

Detailed Summary

This is a randomized, double-blind, placebo-controlled study of the investigational drug uridine as a treatment for depressed adolescents with bipolar disorder (i.e. "bipolar depression"). Participants initially randomized to placebo who complete the 6-week protocol will be offered 6 months of open-label uridine treatment and follow-up. Participants initially randomized to uridine will be offered the open-label treatment as well.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder, Bipolar Depression, Manic Depression
CountriesUnited States
CollaboratorsThe Depressive and Bipolar Disorder Alternative Treatment Foundation

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 6, 2013
Enrollment StartAug 1, 2013
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.3 years ago

Interventions

Uridinedrug

Uridine is the active treatment in this clinical trial.

Placebodrug

Pill placebo is the inactive treatment comparator in this clinical trial.